Article

Taylor, P A; Miles, E; Hoffmann, L; Kelly, S M; Kry, S F; Moller, D S; Palmans, H; Akbarov, K; Aznar, M C; Clemantel, E; Corning, C; Effeney, R; Healy, B; Moore, A; Nakamura, M; Petel, S; Shaw, M; Stock, M; Lehmann, J; Clark, C H (2023) Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison. Radiotherapy and Oncology, 182. 109494

Mir, R; Kelly, S M; Xiao, Y; Moore, A; Clark, C H; Clementel, E; Corning, C; Ebert, M; Hoskin, P; Hurkmans, C W; Ishikura, S; Kristensen, I; Kry, S F; Lehmann, J; Michalski, J M; Monti, A F; Nakamura, M; Thompson, K; Yang, H; Zubizarreta, E; Andratschke, N; Miles, E (2020) Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines. Radiotherapy and Oncology, 150. pp. 30-39. ISSN 01678140

Hussein, M; Clementel, E; Eaton, D J; Greer, P B; Haworth, A; Ishikura, S; Kry, S; Lehmann, J; Lye, J; Monti, A F; Nakamura, M; Hurkmans, C; Clark, C H (2017) A virtual dosimetry audit – Towards transferability of gamma index analysis between clinical trial QA groups. Radiotherapy and Oncology, 125 (3). pp. 398-404. ISSN 01678140